A CRISPR-Cas12a—Based platform for ultrasensitive, rapid, and highly specific detection of Mycoplasma pneumonia in clinical application

Mycoplasma pneumoniae (MP), which is responsible for a majority of community-acquired pneumonia (CAP) in children, has been largely underestimated. Here, we coupled multiple cross displacement amplification (MCDA) technique with CRISPR-Cas12a-based biosensing system to design a novel detection platf...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Nan, Zhou, Juan, Xiao, Fei, Zheng, Baoying, Huang, Xiaolan, Sun, Chunrong, Fu, Jin, Xu, Zheng, Chen, Min, Wang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887289/
https://www.ncbi.nlm.nih.gov/pubmed/36733967
http://dx.doi.org/10.3389/fbioe.2023.1022066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887289/
https://www.ncbi.nlm.nih.gov/pubmed/36733967
http://dx.doi.org/10.3389/fbioe.2023.1022066

Ejemplares similares